Top Insights
MyoKardia
Actualité internationale
World News – United States – Bristol-Myers Squibb Beefs Up Cardiology Franchise with $ 13 1B Deal to Buy Myokardia
Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) is gaining momentum, as company announces multibillion-dollar deal to buy cardio-focused biopharmaceutical Myokardia Inc (NASDAQ: MYOK)
Actualité internationale
World News – US – Bristol Myers completes $ 13 billion MyoKardia buyout
Bristol Myers Squibb has reached a deal to acquire MyoKardia for $ 13 1 billion The all-cash takeover will see Bristol Myers pay...
Actualité internationale
World News – US – Bristol-Myers agrees to buy MyoKardia for $ 13 1 billion
MydoKardia's experimental cardiac treatment, Mavacamten, received a "breakthrough therapy designation" from the US Food & Drug Administration in July of this year
Actualité internationale
World News – US – Bristol-Myers purchases heart drug developer MyoKardia
US drugmaker Bristol-Myers Squibb said Monday it would buy heart drug developer MyoKardia for around $ 13 billion
Actualité internationale
World News – US – Bristol to pay $ 13 billion to heart drug maker MyoKardia
Bristol Myers Squibb, a producer of cancer drugs, said it would buy biotech MyoKardia for $ 13 billion in all-cash transactions to expand...
